HOUSTON | ROMANIA | SOUTHERN AFRICA | MEXICO

HOME | CONTACT 

Case of the Month Sunday, September 22, 2002

 

Cases:
April 2000

May 2000

June 2000

July 2000

August 2000

September 2000

October 2000

November 2000

December 2000

January 2001

February 2001

March 2001

April 2001

May 2001

June 2001

July 2001

August 2001

September 2001

October 2001

November 2001

December 2001

January 2002

February 2002

March 2002

April 2002

May 2002

June 2002

July 2002

 

 

July 2000

Case of the Month: An 8 year old HIV-infected boy presents with a nontender mass in the right submandibular area. Several weeks later copious amounts of pus spontaneously drain from this lesion.

Answer: Tuberculous lymphadenitis (scrofula)

July 2000 Case of the Month Discussion: Lymphadenitis caused by M. tuberculosis is a relatively rare disease. However, with the advent of HIV, tuberculosis has experienced a resurgence, both as a localized and systemic disease. Of particular concern has been the increase in the frequency of multi-drug resistant disease. In an immunocompromised child other causes of lymphadenitis include infections with gram-positive bacteria, atypical mycobacterium and Bartonella henselae (cat scratch disease); malignancies such as lymphoma; masses such as branchial cleft cysts or cystic hygromas masquerading as lymph nodes; and adenitis due to HIV itself. In contrast with immunocompetent children, HIV-infected children with tuberculous lymphadenitis tend to have multifocal disease with a higher prevalence of systemic spread. The most commonly affected lymph nodes are along the upper border of the sternocleidomastoid muscle. Diagnosis can be made with fine needle aspiration, PCR, acid fast stains, and cultures. If available, ultrasound is useful to detect areas of suppuration. Complete excision is recommended to minimize the potential for fistula formation. Once the diagnosis has been made, treatment with three or four anti-tuberculosis drugs for at least six months is recommended. This regimen typically should include isoniazid, rifampin, and pyrazinamide.

 

Copyright © 2002
Baylor International Pediatric AIDS Initiative
All rights reserved